Viatris is a global healthcare company dedicated to improving patient outcomes by enhancing the accessibility of medicines and developing innovative solutions to meet the evolving healthcare needs of communities worldwide. Established in 2020 through a merger between Upjohn, a division of Pfizer, and Mylan, Viatris combines top-tier scientific expertise, manufacturing capabilities, and robust commercial operations to deliver high-quality prescription medications and medical devices.

Offering a diverse range of products, Viatris provides essential prescription drugs, medical devices, and over-the-counter healthcare solutions, making a significant impact on the health of patients. The company is recognized as one of the top healthcare employers in Taiwan and has earned numerous accolades, including placements on prestigious lists such as Forbes' World’s Best Employers and TIME's World’s Best Companies.

With a strong commitment to corporate social responsibility and a focus on sustainability, Viatris aims to remove barriers to medication access while fostering positive health, social, and environmental changes globally.